Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Jasper Therapeutics, Inc. (JSPR) had Return on Equity of -34.53% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.17M |
|
-- |
|
-- |
|
$10.95M |
|
$-10.95M |
|
$9.78M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-10.95M |
|
$-10.93M |
|
28.67M |
|
28.67M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$20.29M |
|
$0.08M |
|
$0.89M |
|
$21.18M |
|
$9.00M |
|
-- |
|
$8.79M |
|
$17.78M |
|
$3.40M |
|
$3.40M |
|
$3.40M |
|
28.00M |
|
| Cash Flow Statement Financials | |
$-14.55M |
|
$0.00M |
|
-- |
|
$29.11M |
|
$14.56M |
|
$-14.55M |
|
$0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-34.53% |
-34.53% |
|
-5.54% |
|
-34.53% |
|
$0.12 |
|
$-0.51 |
|
$-0.51 |
|